Navigation Links
Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients

s that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. There can be no guarantee that a registrational submission will be made to the FDA based on the data described in this press release or if such registrational submission is made, that it would receive FDA approval. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol- Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006 and in our Quarterly Reports on Form 10-Q. Bristol-Myers Squibb undertakes no obligation to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise.

CONTACT: Media and Investor Contacts: Rebecca Gregory, CorporateCommunications of ImClone Systems Incorporated, +1-646-638-5058,; Media: Madeline Malia, +1-609-252-3347,, or Tony Plohoros, +1-609-252-7938,, both of Bristol-Myers Squibb; Bristol-Myers Squibb;or Investors: John Elicker of Bristol-Myers Squibb, +1-212-546-3775, media@imclone.com Madeline.Malia@bms.com tony.plohoros@bms.com John.Elicker@bms.com

Web site: http://www.ERBITUX.com/

Ticker Symbol: (NASDAQ-NMS:IMCL),(NYSE:BMY)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:9/29/2014)... , Sept. 29, 2014  ADM Tronics ... it has entered into an affiliation with Triotech ... Cambridge, Massachusetts founded by ... member of ADMT,s Advisory Board. The ... technology companies with specialized services and finances to ...
(Date:9/29/2014)...  Diplomat, the nation,s largest independent specialty pharmacy, ... named chief information officer. As CIO, Brown will ... department while being responsible for strategic planning, data ... Prior to joining Diplomat, Brown served ... of technology architectures and organizational solutions, new client ...
(Date:9/29/2014)... 29, 2014 Novogen Ltd. (ASX: NRT, NASDAQ: ... , conducted an interview with ABC TV that was broadcast ... bulletin and on the following day on Weekend Breakfast. The ... Trilexium, into the clinic in Australia ... multiforme. The interview provides certain new information ...
Breaking Medicine Technology:ADM Tronics Joins Triotech Ventures Technology Consortium 2ADM Tronics Joins Triotech Ventures Technology Consortium 3Diplomat names Stephen S. Brown chief information officer 2ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 2ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 3
... AUSTIN, Texas, May 24, 2011 A paper published ... demonstrated that adding OVA1 to a physician,s preoperative ... ovarian cancers than a physician,s preoperative assessment alone. The ... the journal, which is the official publication of the ...
... Holdings, Inc. (OTCQB: ABHI), a leader in the development of ... has signed a new line of credit with East West ... to expire July 2011. The new line of credit expands ... the previous revolving line and extends the line by one ...
Cached Medicine Technology:OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 2OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 3OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 4AmbiCom Renews and Expands Line of Credit With East West Bank 2AmbiCom Renews and Expands Line of Credit With East West Bank 3
(Date:9/30/2014)... 30, 2014 Influenza is a significant ... can improve the efficacy of therapy, minimize overuse of ... disease in healthcare settings. Diagnostic tests available today vary ... The decision your laboratory makes in selecting the correct ... providers, is key to effective use of influenza diagnostics. ...
(Date:9/30/2014)... 3M has added four new thin VHB ... 3M 5906 , 3M 5907 , 3M ... which help create the strongest bond possible to a wide ... bonding to difficult surfaces such as paints, low surface energy ... and 5905 are designed specifically for electronic device engineers and ...
(Date:9/30/2014)... Seniors Guide will take part in running ... in Raleigh, to support Alzheimer’s North Carolina (AlzNC) in ... , Associate Publisher of Seniors Guide Magazine, Shannon Tippette, ... for the Raleigh-Durham-Chapel Hill areas of North Carolina for ... helping their team, “Eye of the Tiger”, reach their ...
(Date:9/30/2014)... 30, 2014 American Medical ID and ... agreement to raise awareness about Alzheimer’s disease and related ... people with these brain disorders. , American Medical ID ... AFA to the foundation to support its efforts to ... The ID bracelets and necklaces can be purchased via ...
(Date:9/30/2014)... Charlestown, RI (PRWEB) September 30, 2014 Dogs ... owner. Oftentimes, this involves spending time in the car travelling ... their canines have free run of the vehicle; however, this ... the owner as well. Royal Flush Havanese shares ... should always be routine practice. , There are many ways ...
Breaking Medicine News(10 mins):Health News:Alere Webinar Spotlights Optimal Flu Diagnostics to Keep Your Lab Ahead of the Curve 2Health News:Alere Webinar Spotlights Optimal Flu Diagnostics to Keep Your Lab Ahead of the Curve 3Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 3Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 2Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 3Health News:American Medical ID and Alzheimer’s Foundation of America Team up to Increase Awareness about Alzheimer’s Disease and Related Dementias 2Health News:American Medical ID and Alzheimer’s Foundation of America Team up to Increase Awareness about Alzheimer’s Disease and Related Dementias 3Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 2Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 3
... so does survival, study finds , MONDAY, Feb. 8 (HealthDay ... with increased risk of death, researchers say. , In a ... again at age 89 in a group of 555 participants ... at 85 and 89 years, and a greater decline in ...
... ... Strash, FACHE, Chief Executive Officer with Oro Valley Hospital, on critical issues facing healthcare ... ... timely communication among different segments of the medical community, Jackson & Coker ( www.jacksoncoker.com ...
... , CINCINNATI , Feb. 8 Three ... "about right," according to a study of more than 65,000 ... of obesity over the past several years, the number of ... 1999 and 2007," says Nicholas M. Edwards , MD, ...
... triggering bone formation , MONDAY, Feb. 8 (HealthDay News) -- ... osteoporosis in lab mice and rats, a new study has ... gut hinders bone formation. Most current drugs for osteoporosis only ... "New therapies that inhibit the production of serotonin in the ...
... BETHESDA, Md. , Feb. 8 /PRNewswire-Asia/ ... Western healthcare,products and services in the People,s Republic of China , today ... , , Financial Highlights:, -- Revenue in ... over year to $46.5 million;, -- Net ...
... ... McDonald, have formed One2One Partners. The firm creates customized programs that strengthen the relationship ... an engaged workforce and minimize the threat of third-party intervention, regardless of potential legislation ... ...
Cached Medicine News:Health News:Handgrip Strength Helps Predict Death Risk in Elderly 2Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 2Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 3Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 4Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 5Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 6Health News:New Study Shows Nearly One Third of Overweight Adolescents See Themselves as Underweight or 'About Right' 2Health News:New Study Shows Nearly One Third of Overweight Adolescents See Themselves as Underweight or 'About Right' 3Health News:Drug Cures Osteoporosis in Mice 2Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 2Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 3Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 4Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 5Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 6Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 7Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 8Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 9Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 10Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 11Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 12Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 13Health News:Labor and Employee Relations Experts Form New Consulting Firm 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: